Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.33 |
| ▸ | PPARA | Q07869 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CTSS | P25774 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3581957 | 0.76 | TSHR (0.42) | L3MBTL1ALOX5KDM4EPOLBALDH1A1 | |
| SCHEMBL5139257 | 0.70 | PARP10 (0.42) | L3MBTL1ALOX5KDM4EPOLBALDH1A1 | |
| SCHEMBL3586429 | 0.68 | SMN1; SMN2 (0.41) | L3MBTL1PPARAALDH1A1CTSSSMN1; SMN2 | |
| SCHEMBL3594233 | 0.67 | HTT (0.41) | L3MBTL1NPSR1PPARAPOLBCTSS | |
| SCHEMBL2321110 | 0.66 | ALDH1A1 (0.50) | L3MBTL1ALDH1A1 | |
| SCHEMBL10666425 | 0.66 | ALDH1A1 (0.50) | L3MBTL1ALDH1A1 | |
| SCHEMBL3585655 | 0.66 | SMN1; SMN2 (0.38) | PPARAKDM4EPOLBALDH1A1CTSS | |
| SCHEMBL3580905 | 0.66 | TGM2 (0.41) | L3MBTL1NPSR1PPARAPOLBCTSS | |
| SCHEMBL5499571 | 0.66 | TSHR (0.54) | L3MBTL1ALOX5ALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL3582786 | 0.65 | SMN1; SMN2 (0.46) | KDM4ESMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100048549-A1 | Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 | Wurster, Siegfried (FI) | 2010-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048549-A1 | Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 | SSTR1, SSTR4, SSTR3 | L3MBTL1 3305/4885NPSR1 13/4885ALOX5 4584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.